152 related articles for article (PubMed ID: 27604660)
21. The relationship between the VEGF/sVEGFR-1 ratio and threatened abortion.
Keskin U; Ulubay M; Dede M; Ozgurtas T; Koçyiğit YK; Aydin FN; Ergün A
Arch Gynecol Obstet; 2015 Mar; 291(3):557-61. PubMed ID: 25200689
[TBL] [Abstract][Full Text] [Related]
22. Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension.
Tsai WC; Li YH; Huang YY; Lin CC; Chao TH; Chen JH
Clin Sci (Lond); 2005 Jul; 109(1):39-43. PubMed ID: 15740459
[TBL] [Abstract][Full Text] [Related]
23. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.
Kikuchi S; Obata Y; Yagyu K; Lin Y; Nakajima T; Kobayashi O; Kikuichi M; Ushijima R; Kurosawa M; Ueda J
Cancer Sci; 2011 Apr; 102(4):866-9. PubMed ID: 21219538
[TBL] [Abstract][Full Text] [Related]
24. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
[TBL] [Abstract][Full Text] [Related]
25. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry).
Kądziela J; Prejbisz A; Kostka-Jeziorny K; Dudek D; Narkiewicz K; Sadowski J; Lekston A; Gziut A; Więcek A; Buszman P; Kleinrok A; Kochman J; Czarnecka D; Januszewicz A; Witkowski A
Kardiol Pol; 2016; 74(9):961-8. PubMed ID: 27160171
[TBL] [Abstract][Full Text] [Related]
26. Integrative Blood Pressure Response to Upright Tilt Post Renal Denervation.
Howden EJ; East C; Lawley JS; Stickford ASL; Verhees M; Fu Q; Levine BD
Am J Hypertens; 2017 Jun; 30(6):632-641. PubMed ID: 28338768
[TBL] [Abstract][Full Text] [Related]
27. Biomarker response and therapy prediction in renal denervation therapy - the role of MR-proadrenomedullin in a multicenter approach.
Neumann JT; Schwerg M; Dörr O; Mortensen K; Franzen K; Zeller T; Ojeda F; Blankenberg S; Hamm C; Nef H; Stangl V; Möckel M; Sydow K
Biomarkers; 2017; 22(3-4):225-231. PubMed ID: 27153479
[TBL] [Abstract][Full Text] [Related]
28. Circulating biomarkers of bevacizumab activity in patients with breast cancer.
Denduluri N; Yang SX; Berman AW; Nguyen D; Liewehr DJ; Steinberg SM; Swain SM
Cancer Biol Ther; 2008 Jan; 7(1):15-20. PubMed ID: 18059178
[TBL] [Abstract][Full Text] [Related]
29. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
[TBL] [Abstract][Full Text] [Related]
30. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels.
Lambert T; Nahler A; Reiter C; Gammer V; Blessberger H; Kammler J; Grund M; Saleh K; Schwarz S; Steinwender C
Catheter Cardiovasc Interv; 2015 Sep; 86(3):E126-30. PubMed ID: 26033366
[TBL] [Abstract][Full Text] [Related]
31. Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Hori S
Am J Ophthalmol; 2011 Oct; 152(4):669-677.e1. PubMed ID: 21726846
[TBL] [Abstract][Full Text] [Related]
32. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension.
Hering D; Lambert EA; Marusic P; Walton AS; Krum H; Lambert GW; Esler MD; Schlaich MP
Hypertension; 2013 Feb; 61(2):457-64. PubMed ID: 23172929
[TBL] [Abstract][Full Text] [Related]
33. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
[TBL] [Abstract][Full Text] [Related]
34. Effects of renal denervation on heart failure biomarkers and blood pressure in patients with resistant hypertension.
Neumann JT; Ewen S; Mortensen K; Nef H; Zeller T; Ojeda F; Sydow K; Mahfoud F; Böhm M; Hamm C; Dörr O; Blankenberg S
Biomark Med; 2016 Aug; 10(8):841-51. PubMed ID: 27428075
[TBL] [Abstract][Full Text] [Related]
35. Intraprocedural reduction of the veno-arterial norepinephrine gradient correlates with blood pressure response after renal denervation.
Tiroch K; Sause A; Szymanski J; Nover I; Leischik R; Mann JF; Vorpahl M; Seyfarth M
EuroIntervention; 2015 Nov; 11(7):824-34. PubMed ID: 26603990
[TBL] [Abstract][Full Text] [Related]
36. Copeptin, resistant hypertension and renal sympathetic denervation.
Schwerg M; Slagman A; Stangl K; Stangl V
Biomarkers; 2017; 22(3-4):311-314. PubMed ID: 27775435
[TBL] [Abstract][Full Text] [Related]
37. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
[TBL] [Abstract][Full Text] [Related]
38. Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet's uveitis.
Sertoglu E; Yücel Ç; Omma A; Hayran Y; Colak S; Sandıkçı SC; Durukan AH; Ozgurtas T
Adv Clin Exp Med; 2022 Mar; 31(3):231-240. PubMed ID: 34918882
[TBL] [Abstract][Full Text] [Related]
39. Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1.
Allanore Y; Borderie D; Lemaréchal H; Ekindjian OG; Kahan A
Arthritis Res Ther; 2004; 6(4):R309-14. PubMed ID: 15225366
[TBL] [Abstract][Full Text] [Related]
40. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.
Tsioufis C; Papademetriou V; Tsiachris D; Kasiakogias A; Kordalis A; Thomopoulos C; Dimitriadis K; Tousoulis D; Stefanadis C; Parati G; Worthley S
Int J Cardiol; 2015 Feb; 180():237-42. PubMed ID: 25463375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
